Low-dose methotrexate in dermatology: the utility of serological monitoring in a real-world cohort.

Hajar, Tamar; Latour, Emile J; Haynes, Dylan; Topham, Christina; Hill, Emma E; Simpson, Eric L; Greiling, Teri M

Hajar, Tamar; Latour, Emile J; Haynes, Dylan; Topham, Christina; Hill, Emma E; Simpson, Eric L; Greiling, Teri M.

Afiliação

Hajar T; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Latour EJ; Department of Dermatology,University of Colorado, Denver, CO, USA.
Haynes D; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Topham C; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Hill EE; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
Simpson EL; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.
Greiling TM; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

J Dermatolog Treat ; 33(4): 2161-2167, 2022 Jun.

Article em En | MEDLINE | ID: mdl-34148493

Assuntos

Dermatologia; Metotrexato; Aspartato Aminotransferases; Estudos de Coortes; Humanos; Metotrexato/efeitos adversos; Estudos Retrospectivos

Palavras-chave

Methotrexate (MeSH ID D008727); drug monitoring (MeSH ID D016903); drug-related side effects and adverse reactions (MeSH ID D064420); skin diseases (MeSH ID D012871)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metotrexato / Dermatologia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google